This review describes a class of etiotropic (direct-acting) antiviral agents that act by altering the conformation of microbial proteins and thereby disrupting their functions. Examples of peptides capable of inducing a prion-like change in viral protein conformation are considered. The potential applications of such compounds and potential challenges associated with their use are discussed.